NDC 0555-0344
Errin
Norethindrone
Errin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa,. The primary component is Norethindrone.
| Product ID | 0555-0344_528976e6-d066-4e61-b1a6-8bd4ab72af37 |
| NDC | 0555-0344 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Errin |
| Generic Name | Norethindrone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2003-01-08 |
| Marketing End Date | 2019-03-31 |
| Marketing Category | ANDA / |
| Application Number | ANDA076225 |
| Labeler Name | Teva Pharmaceuticals USA, |
| Substance Name | NORETHINDRONE |
| Active Ingredient Strength | 0 mg/1 |
| Pharm Classes | Progesterone Co |
| NDC Exclude Flag | N |
Packaging
NDC SPL Data Element Entries
NDC 0555-0344-79 [00555034479]
Errin TABLET
| Marketing Category | ANDA |
| Application Number | ANDA076225 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-05-03 |
| Marketing End Date | 2019-03-31 |
NDC 0555-0344-58 [00555034458]
Errin TABLET
| Marketing Category | ANDA |
| Application Number | ANDA076225 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2003-01-08 |
| Marketing End Date | 2019-03-31 |
Drug Details
NDC Crossover Matching brand name "Errin" or generic name "Norethindrone"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0555-0344 | Errin | Norethindrone |
| 51862-100 | Errin | Norethindrone |
| 51862-886 | ERRIN | NORETHINDRONE |
| 71205-526 | ERRIN | ERRIN |
| 51862-102 | Camila | Norethindrone |
| 51862-884 | CAMILA | NORETHINDRONE |
| 16714-440 | DEBLITANE | Norethindrone |
| 57297-877 | Jencycla | norethindrone |
| 52544-892 | Jolivette | NORETHINDRONE |
| 50102-300 | Lyleq | NORETHINDRONE |
| 53002-1793 | Lyleq | NORETHINDRONE |
| 50102-100 | LYZA | norethindrone |
| 53002-1687 | LYZA | norethindrone |
| 52544-629 | Nora BE | Norethindrone |
| 0378-7272 | Norethindrone | Norethindrone |
| 0378-7292 | NORETHINDRONE | norethindrone |
| 50090-2150 | Norethindrone | Norethindrone |
| 50090-6161 | NORETHINDRONE | NORETHINDRONE |
| 57297-876 | NORETHINDRONE | NORETHINDRONE |
| 63187-748 | Norethindrone | Norethindrone |
| 42291-650 | Norethindrone Acetate | Norethindrone |
| 50268-602 | Norethindrone Acetate | Norethindrone |
| 50090-3235 | Norlyda | norethindrone |
| 51660-127 | NORLYROC | norethindrone |
| 50458-194 | Ortho Micronor | NORETHINDRONE |
| 16714-441 | SHAROBEL | Norethindrone |
| 50102-200 | Tulana | NORETHINDRONE |
| 53002-2687 | Tulana | NORETHINDRONE |
Trademark Results [Errin]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ERRIN 76317691 2727955 Live/Registered |
MAYNE PHARMA LLC 2001-09-26 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.